Iman A Y Ghannam

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Molecular Docking

Cell Cycle Arrest

Papillary Thyroid

High Throughput

Top Venues

Archiv der Pharmazie

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Heba T Abdel-Mohsen, Amira M Nageeb, Iman A Y Ghannam
Diphenyl urea-benzylidene acetohydrazide hybrids as fibroblast growth factor receptor 1 inhibitors and anticancer agents. Drug development research 85 (6) (2024)
Heba T Abdel-Mohsen, Amira M Nageeb, Iman A Y Ghannam
Diphenyl urea-benzylidene acetohydrazide hybrids as fibroblast growth factor receptor 1 inhibitors and anticancer agents. Drug development research 85 (6) (2024)
Iman A Y Ghannam, Ahmed M El Kerdawy, Marwa M Mounier, Mahmoud T Abo-Elfadl, Islam H Ali
Novel 2-oxo-2-phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR-2 inhibitors: Design, synthesis, and anticancer evaluation. Archiv der Pharmazie (2022)
Rasha M Hassan, Islam H Ali, Mohammed S Abdel-Maksoud, Heba M I Abdallah, Ahmed M El Kerdawy, Francesca Sciandra, Iman A Y Ghannam
Design and synthesis of novel quinazolinone-based fibrates as PPARα agonists with antihyperlipidemic activity. Archiv der Pharmazie 355 (3) (2021)
Hanaa M Roaiah, Iman A Y Ghannam, Islam H Ali, Ahmed M El Kerdawy, Mamdouh M Ali, Safinaz E-S Abbas, Sally S El-Nakkady
Design, synthesis, and molecular docking of novel indole scaffold-based VEGFR-2 inhibitors as targeted anticancer agents. Archiv der Pharmazie 351 (2) (2018)